Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib
Crossref DOI link: https://doi.org/10.1007/s10147-017-1214-y
Published Online: 2017-11-13
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eskazan, Ahmet Emre http://orcid.org/0000-0001-9568-0894
License valid from 2017-11-13